Phosphorus levels are associated with subclinical atherosclerosis in the general population

Atherosclerosis

Volumn 199, Issue 2, 2008, Pages 424-431

  Onufrak, Stephen J ^a,b   Bellasi, Antonio ^b   Shaw, Leslee J ^b   Herzog, Charles A ^c   Cardarelli, Francesca ^b   Wilson, Peter W ^b   Vaccarino, Viola ^a,b   Raggi, Paolo ^b  

^a EMORY UNIVERSITY   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HENNEPIN COUNTY MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Carotid intima media thickness; Phosphorus

Indexed keywords

FIBRINOGEN; PHOSPHORUS;

ADULT; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; COHORT ANALYSIS; DATA ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FIBRINOGEN BLOOD LEVEL; GLOMERULUS FILTRATION RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; SEX DIFFERENCE; STATISTICAL MODEL; STATISTICAL SIGNIFICANCE; STROKE;

ATHEROSCLEROSIS; CHOLESTEROL; COHORT STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; PHOSPHORUS; RISK; TUNICA INTIMA; TUNICA MEDIA;

EID: 47649130608     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.11.004     Document Type: Article

References (27)

1. Kestenbaum B., Sampson J.N., Rudser K.D., et al. Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16 (2005) 520-528
2. Block G.A., Hulbert-Shearon T.E., Levin N.W., and Port F.K. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31 (1998) 607-617
3. Ganesh S.K., Stack A.G., Levin N.W., Hulbert-Shearon T., and Port F.K. Association of elevated serum PO(4), Ca × PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12 (2001) 2131-2138
4. Stevens L.A., Djurdjev O., Cardew S., Cameron E.C., and Levin A. Calcium, phosphate, and parathyroid hormone levels in combination and as a function of dialysis duration predict mortality: evidence for the complexity of the association between mineral metabolism and outcomes. J Am Soc Nephrol 15 (2004) 770-779
5. Dhingra R., Sullivan L.M., Fox C.S., et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167 (2007) 879-885
6. Tonelli M., Sacks F., Pfeffer M., Gao Z., and Curhan G. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112 (2005) 2627-2633
7. Narang R., Ridout D., Nonis C., and Kooner J.S. Serum calcium, phosphorus and albumin levels in relation to the angiographic severity of coronary artery disease. Int J Cardiol 60 (1997) 73-79
8. Amann K., Tornig J., Kugel B., et al. Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney Int 63 (2003) 1296-1301
9. Goodman W.G., Goldin J., Kuizon B.D., et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342 (2000) 1478-1483
10. Raggi P., Boulay A., Chasan-Taber S., et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease?. J Am Coll Cardiol 39 (2002) 695-701
11. Kalantar-Zadeh K., Kuwae N., Regidor D.L., et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70 (2006) 771-780
12. Kalaitzidis R., Tsimihodimos V., Bairaktari E., Siamopoulos K.C., and Elisaf M. Disturbances of phosphate metabolism: another feature of metabolic syndrome. Am J Kidney Dis 45 (2005) 851-858
13. Chan C.T., Wells H., and Kramsch D.M. Suppression of calcific fibrous-fatty plaque formation in rabbits by agents not affecting elevated serum cholesterol levels. The effect of thiophene compounds. Circ Res 43 (1978) 115-125
14. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 1989; 129: 687-702.
15. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (Suppl. 1): S1-S266.
16. Manjunath G., Tighiouart H., Ibrahim H., et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41 (2003) 47-55
17. National Heart, Lung, and Blood Institute, and Atherosclerosis Risk in Communities [ARIC] Study. Operations manual, number 6A: ultrasound scanning methods, version 1.0. Chapel Hill, NC (1987), ARIC Coordinating Center, School of Public Health, Univesity of North Carolina
18. National Heart, Lung, and Blood Institute, and Atherosclerosis Risk in Communities [ARIC] Study. Operations manual, number 6B: ultrasound scanning methods, version 1.0. Chapel Hill, NC (1987), ARIC Coordinating Center, School of Public Health, Univesity of North Carolina
19. Levin A., Bakris G.L., Molitch M., et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71 (2007) 31-38
20. Wu-Wong J.R., Nakane M., Ma J., Ruan X., and Kroeger P.E. Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells. Am J Physiol Ren Physiol (22 August 2007) [Epub ahead of print]
21. Jono S., McKee M.D., Murry C.E., et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87 (2000) E10-E17
22. Arking D.E., Atzmon G., Arking A., Barzilai N., and Dietz H.C. Association between a functional variant of the KLOTHO gene and high-density lipoprotein cholesterol, blood pressure, stroke, and longevity. Circ Res 96 (2005) 412-418
23. Arking D.E., Becker D.M., Yanek L.R., et al. KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am J Hum Genet 72 (2003) 1154-1161
24. Nadra I., Mason J.C., Philippidis P., et al. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification?. Circ Res 96 (2005) 1248-1256
25. Chambless L.E., Heiss G., Folsom A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993. Am J Epidemiol 146 (1997) 483-494
26. O'Leary D.H., Polak J.F., Kronmal R.A., et al., Cardiovascular Health Study Collaborative Research Group. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 340 (1999) 14-22
27. Lorenz M.W., Markus H.S., Bots M.L., Rosvall M., and Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 115 (2007) 459-467